# TCR Alpha/Beta and CD19-deplete Haplo-HSCT

> **NCT05288595** · PHASE2 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Pediatric Patients
- Hematologic Malignancy
- Other Hematologic Condition

## Interventions

- **DEVICE:** CliniMACS Plus Instrument

## Key facts

- **NCT ID:** NCT05288595
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12
- **Primary completion:** 2026-04
- **Final completion:** 2028-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancelled by Sponsor
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05288595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05288595, "TCR Alpha/Beta and CD19-deplete Haplo-HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05288595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*